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This year the Lasker Foundation pays tribute to telomerase, a medically important enzyme 
required for chromosome stability and long-term cell proliferation.On September 29, the 2006 Albert 
Lasker Award for Basic Medical 
Research will be conferred on Eliza-
beth Blackburn, Carol Greider, and 
Jack Szostak. They are recognized 
for the discovery of telomerase, the 
enzyme that maintains telomeres, 
and the demonstration that immortal 
growth of eukaryotic cells requires 
the maintenance of telomeric DNA. 
Telomerase has achieved biomedical 
fame for its ability to propel cancer 
cells beyond their original expiration 
date. Telomerase activity, or lack 
thereof, has been used as a diag-
nostic tool for malignancies, and its 
inhibitors hold therapeutic promise 
for treating human cancer. Enthusi-
asm for telomerase is also fueled by 
its ability to endow normal human 
cells with infinite proliferative poten-
tial, an attribute relevant to the manip-
ulation of stem cells and attempts at 
tissue regeneration. These biomedi-
cal merits clearly warrant recognition 
of telomerase and its discoverers. 
This enzyme did not emerge from 
research on cancer or aging, how-
ever. It was found as a solution to 
one of the most basic problems in 
cell biology, and the story of its dis-
covery is worth telling.
Despite its medical importance, 
telomerase emerged from work on 
two organisms that pose no threat 
to human health: baker’s yeast and 
the harmless pond-dwelling cili-
ate, Tetrahymena thermophila. In 
the mid-1970s, Elizabeth Blackburn 
learned about Tetrahymena’s experi-
mental virtues from Joseph Gall, her 
postdoctoral advisor and recipient 
of this year’s Albert Lasker Special 
Achievement Award. Working with 
Gall, Blackburn encountered the first 
eukaryotic telomeric sequences while studying the ciliate’s ribosomal DNA 
(rDNA), a small linear DNA that codes 
for the RNA components of ribos-
omes. Like rDNA in other eukaryotes, 
the rDNA of Tetrahymena is present 
at high copy number. This allowed 
Blackburn and Gall to isolate large 
amounts of this DNA without having 
to resort to the nascent recombinant 
DNA technology of those days. 
Despite experimental hurdles, they 
deduced the nucleotide sequence of 
the ends of this minute chromosome 
and concluded that they were made 
up of 20–70 tandem copies of the 
sequence TTGGGG (Blackburn and 
Gall, 1978). No other chromosome 
end sequence was available at that 
time, so Blackburn and Gall could 
not anticipate that their findings on 
rDNA ends would be repeated for 
most eukaryotic telomeres.
In parallel with this early work by 
Blackburn and Gall, a theoretical 
discussion about the consequences 
of DNA replication was in progress. 
Jim Watson pointed out that the 
canonical DNA replication strategy 
could not account for duplication of 
the ends of linear genomes (Watson, 
1972). Theoretical solutions for this 
“end-replication problem” either 
invoked recombination between the 
repetitive sequences or a hairpin 
loop that would allow polymerases 
to turn around and complete their 
task. Watson’s considerations, and 
a related discussion by Olovnikov 
(Olovnikov, 1973), were a preview 
of experimental observations about 
to unfold.
In 1981, Jack Szostak reported on 
a different problem associated with 
DNA ends. Working with his student, 
Terry Orr-Weaver, and a collaborator, 
Rodney Rothstein, he described the Cell 126, Septefate of linear DNAs introduced into 
budding yeast (Orr-Weaver et al., 
1981). They found that the ends of 
newly introduced linear DNAs were 
highly recombinogenic, such that the 
plasmids invariably integrated into 
homologous sequences in the yeast 
genome. In some cases, however, 
the ends were degraded or ligated in 
a recombination-independent man-
ner. These findings echoed obser-
vations made by Barbara McClin-
tock and Hermann Muller half a 
century earlier. They had surmised 
that broken chromosome ends were 
unstable and differed from natu-
ral chromosome ends, which car-
ried what Muller termed a telomere 
(for the Greek word for end, telos). 
The nature of this telomere was not 
known then and is only partially 
understood today. A harbinger of 
future findings on human telomerase 
was Barbara McClintock’s discovery 
that new telomeres could be synthe-
sized in maize embryos but not in 
mature plants. We now understand 
that this is probably due to differen-
tial expression of telomerase.
Whereas the recombination of lin-
ear plasmids introduced into yeast 
(and mouse embryonic stem cells, 
as it later turned out) opened the way 
for gene targeting, the integration of 
the introduced DNAs thwarted Szos-
tak’s attempts to generate artificial 
chromosomes. Upon learning about 
the structure of Tetrahymena rDNA 
ends, Szostak hoped that they might 
block recombination and thus sta-
bilize introduced plasmids in linear 
form. Accordingly, Szostak collabo-
rated with Blackburn to force a union 
between Tetrahymena rDNA ends 
and a linear yeast plasmid. Capped 
with Tetrahymena repeats, the plas-mber 22, 2006 ©2006 Elsevier Inc. 1017
Figure 1. The Discovery of Telomerase and Its Role in Cellular Proliferation
(A) The telomerase assay performed by Greider and Blackburn, using extracts of the ciliate Tet-
rahymena at various time points after mating, showed telomerase activity at the time of extensive 
de novo telomere synthesis (Greider and Blackburn, 1985). 
(B) Plasmid resolution assay used by Lundblad and Szostak to screen for yeast mutants deficient 
in telomere synthesis (Lundblad and Szostak, 1989). 
(C) Plate showing the delayed senescence phenotype of the est1-1 (“ever shortening telomeres”) 
yeast mutant that has a defect in telomerase (Lundblad and Szostak, 1989).mid ends no longer recombined and 
the DNAs were maintained as linear 
replicating yeast episomes (Szostak 
and Blackburn, 1982). Szostak and 
Blackburn then asked whether they 
could capture a yeast telomere if 
they capped only one end of the 
plasmid with rDNA and then ligated 
yeast DNA to the other end. The 
yeast telomeres they cloned in this 
way were made up of short irregular 
repeats that, like Tetrahymena telo-1018 Cell 126, September 22, 2006 ©20meric repeats, had TG sequences in 
the strand running out to the 3′ end 
of the chromosome (Shampay et al., 
1984). They also found that these 
yeast telomeric repeats were added 
to the plasmid ends capped with 
Tetrahymena repeats. In a remark-
able reaction that lacked an appar-
ent template for DNA polymerization, 
budding yeast had added approxi-
mately 200 basepairs of its own 
telomeric DNA to the ends, and this 06 Elsevier Inc.addition was ultimately responsible 
for the stability of the linear DNAs.
What was the nature of this untem-
plated telomere repeat addition 
reaction? Szostak and Blackburn 
realized that the “hairpin” model 
of end replication, in vogue at that 
time, was in discordance with their 
findings; nor could recombination 
explain the sequence addition they 
observed. Therefore, Szostak and 
Blackburn favored the idea of a ter-
minal transferase-like enzyme that 
was dedicated to adding repeats 
onto chromosome ends. If there was 
such an enzyme, they speculated, 
its main role could be to fix Watson’s 
end-replication problem. Although 
invoking an unknown enzyme might 
have seemed far-fetched, the pro-
posal fit with Barbara McClintock’s 
view of telomere synthesis. As 
McClintock explained in a 1983 let-
ter to Blackburn (http://profiles.nlm.
nih.gov/LL/), her finding of a maize 
stock that lacked the ability to heal 
the ends of broken chromosomes in 
the plant embryo had suggested to 
her that “this mutant affects the pro-
duction or the action of an enzyme 
required for formation of a new 
telomere.” A telomere-synthesizing 
enzyme could also explain the curi-
ous observation made by Piet Borst 
and colleagues that telomeres in the 
protozoan parasite Trypanosoma 
brucei grew steadily by ?6 basepa-
irs with each cell division (Bernards 
et al., 1983), as well as the findings 
from several groups that new telo-
meric repeats were added to DNA 
fragments created during ciliate 
development.
Blackburn and Szostak went in 
different directions to try to find 
evidence for the hypothetical tel-
omere-synthesizing enzyme. Black-
burn took a biochemical approach 
using extracts from mating Tetrahy-
mena, expecting that the proposed 
enzyme would be abundant at that 
stage. Ciliates have two nuclei, one 
of which, the micronucleus, is only 
used for meiosis and sexual conju-
gation. The macronucleus is the site 
of gene expression, and its genome 
is formed after mating by chromo-
some fragmentation and addition of 
telomeres to the DNA ends. Joined 
in her efforts by her graduate stu-
dent, Carol Greider, Blackburn set 
up various assays that might detect 
telomere synthesis in vitro. After trial 
and error, they detected an enzyme 
activity that added sequences to 
the 3′ end of an oligonucleotide 
containing TTGGGG repeats. The 
enzyme worked well on this telom-
eric primer and a similar oligonucle-
otide representing yeast telomeric 
DNA but ignored the C-rich telom-
eric sequences of the other strand. 
The product was a ladder with a 6 
basepair periodicity composed of 
only Gs and Ts. As predicted, the 
enzyme activity was greater after 
mating (see Figure 1), and several 
control experiments argued that this 
was a new type of DNA polymer-
ase activity. All the data pointed to 
the telomere-synthesizing activ-
ity hypothesized by Blackburn and 
Szostak; telomerase, as it later 
became known, had been found 
(Greider and Blackburn, 1985).
The enzymatic activity that Grei-
der and Blackburn were character-
izing had two remarkable features 
(Greider and Blackburn, 1987, 1989). 
First, the enzyme always added the 
correct sequence, the TTGGGG 
repeat of Tetrahymena telomeres. 
Second, the enzyme was able to dis-
cern the sequence of the DNA end 
that it was acting on. For instance, 
when they provided the enzyme 
with an oligonucleotide ending in 
TTGGG, the enzyme would first add 
a G, before adding two Ts. Greider 
and Blackburn correctly guessed 
that the enzyme used a nucleic acid 
as a template and showed that this 
guide was composed of RNA. When 
they isolated the telomerase RNA, 
they found that it contained the tem-
plate for 1.5 telomeric repeats. This 
template region both specifies the 
telomeric DNA and helps the enzyme 
to recognize the phasing of the last 
repeat at the chromosome end. 
Blackburn’s group eventually proved 
that the RNA specified the sequence 
of the telomeres by showing that 
mutated RNAs could reprogram tel-
omerase to synthesize mutant tel-
omeres (Yu et al., 1990). Thus, tel-omerase turned out to be a reverse 
transcriptase that copied part of its 
associated RNA using the 3′ end of 
the chromosome as a primer.
In 1984, Szostak and his postdoc-
toral fellow, Vicki Lundblad, had initi-
ated their own hunt for genes involved 
in telomere synthesis. They developed 
a genetic screen based on the fate of 
plasmids carrying two Tetrahymena 
telomeric repeat arrays in opposite 
orientation (Lundblad and Szostak, 
1989) (see Figure 1). They knew that 
yeast had the ability to spontane-
ously resolve these plasmids into lin-
ear DNAs, losing whatever sequence 
was inserted between the telomeres. 
Because this reaction required addi-
tion of yeast telomeres to the ends of 
the plasmid, Lundblad and Szostak 
predicted that a telomerase mutant 
would be defective in the lineariza-
tion of the plasmid. To monitor the 
linearization reaction, they placed the 
URA3 gene in between the telom-
eres. The URA3 marker had just been 
developed as a gene one could select 
either for (on culture plates lacking 
uracil) or against (with 5-Fluorootic 
acid; 5-FOA). After mutagenesis 
with ethylmethanesulfonate, Lund-
blad and Szostak monitored yeast 
strains for their ability to lose the URA3 
gene while retaining the plasmid. One 
mutant out of 7000 strains examined 
not only had the expected behavior 
(diminished frequency of colonies 
resistant to 5-FOA) but also failed to 
maintain native telomeres. Examina-
tion of chromosome ends showed 
that this mutant gradually lost its tel-
omeric DNA, an attribute referred to 
in the name of the gene, ever shorter 
telomeres 1 (EST1). Clearly, EST1 
was required for telomere mainte-
nance as well as de novo telomere 
formation. Later work showed that 
the Est1 protein is a component of 
the yeast telomerase complex and 
is required for telomerase function 
in vivo (reviewed in Lundblad, 2003). 
The observation that est1-1 cells had 
ever shorter telomeres represented 
experimental verification of the end 
replication problem.
Yeast strains lacking Est1 had 
two additional striking phenotypes. 
Although their initial growth was Cell 126, Septenormal, the est1-1 strain lost vigor 
after prolonged culture and eventu-
ally stopped growing altogether (see 
Figure 1). Lundblad and Szostak 
concluded that the telomere short-
ening of est1-1 mutants induced 
senescence with delayed onset. The 
phenotypic lag could be explained if 
yeast telomeres were considerably 
longer than the minimum needed 
for chromosome end protection. 
Lundblad and Szostak also noted a 
high rate of chromosome loss that 
appeared after prolonged culture 
and was coincident with senes-
cence. Thus, their data showed that 
loss of telomerase and the accom-
panying telomere attrition eventu-
ally resulted in genome instability 
and replicative senescence. It did 
not escape their attention that their 
findings could explain the fate of pri-
mary human cells, which undergo 
senescence after ?50 cell divisions 
and show chromosomal aberrations 
at the end of their replicative life 
span (Hayflick, 1965).
Epilogue
This tale of telomerase and telom-
eres ends in 1990, before the full 
implications of this discovery were 
realized (Cech, 2004). A few years 
later, the medical community took 
note of telomerase when a sensi-
tive assay revealed that its activity is 
widespread in human cancer; normal 
human cells showed up negative in 
this assay. The absence of telom-
erase and the fact that telomeres 
of primary human cells continually 
shorten suggested that their repli-
cative senescence could be due to 
telomere loss. To test this proposal, 
it was necessary to find a way to 
activate telomerase. With the iden-
tification of the telomerase reverse 
transcriptase (TERT), yet again from 
a ciliate (this time Euplotes) and from 
yeast, and the subsequent isolation 
of the human ortholog, hTERT, this 
crucial experiment became possible. 
When introduced into primary human 
cells, hTERT reconstituted robust tel-
omerase activity and this abrogated 
telomere shortening. As predicted, 
such cells do not undergo replica-
tive senescence; they are immor-mber 22, 2006 ©2006 Elsevier Inc. 1019
tal. This result not only proved the 
concept of a telomere-dependent 
mitotic clock but also solidified the 
view of telomere attrition as a tumor 
suppressor mechanism that can limit 
the progression of human malignan-
cies. Given that most human cancers 
by-pass this block by activating tel-
omerase, telomerase inhibitors are 
predicted to have broad efficacy and 
relatively mild side effects.
The question of whether telomere 
attrition contributes to aging phe-
notypes has proven much harder 
to address, in part because telom-
eres do not shorten naturally in the 
few animals amenable to genetic 
manipulation. However, patients 
with inherited deficiencies in telom-
erase develop severe hematological 
symptoms, suggesting that telomere 
shortening can wreak havoc in the 
bone marrow. The contribution of 
telomere attrition to blood disorders 
and other conditions in the aged is 1020 Cell 126, September 22, 2006 ©20not yet understood, and it remains 
to be seen whether manipulation of 
telomerase can be beneficial in these 
and other contexts. Hopefully, the 
story of telomerase will not come to 
an end before its tremendous prom-
ise has paid off in the clinic. In the 
meantime, we also need to unravel 
a related puzzle: how do telomeres, 
the product of telomerase, protect 
chromosome ends?
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